Oncotelic Therapeutics (OTLC) Income towards Parent Company (2010 - 2026)
Oncotelic Therapeutics (OTLC) posted Income towards Parent Company of $388,147 for Q2 2026, up 39.7% from $277,856 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Income towards Parent Company (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at Oncotelic Therapeutics was $249.99 million; for FY2025, it came in at $249.3 million.
- In prior years, Oncotelic Therapeutics' Income towards Parent Company was -$4.52 million in FY2024, -$7.9 million in FY2023, $5.09 million in FY2022 and -$9.39 million in FY2021.
- Quarterly Income towards Parent Company has run from a low of -$6.76 million in Q2 2023 to a high of $250.37 million in Q4 2025 over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 388,147.00 |
| Dec 31, 2025 | 250.37 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | 277,856.00 |
| Mar 31, 2025 | -298,716.00 |
| Dec 31, 2024 | -600,934.00 |
| Sep 30, 2024 | -3.30 Mn |
| Jun 30, 2024 | -209,837.00 |
| Mar 31, 2024 | -408,676.00 |
| Dec 31, 2023 | -735,983.00 |
| Sep 30, 2023 | 115,309.00 |
| Jun 30, 2023 | -6.76 Mn |
| Mar 31, 2023 | -525,419.00 |
| Dec 31, 2022 | -5.29 Mn |
| Sep 30, 2022 | -777,935.00 |
| Jun 30, 2022 | 16.01 Mn |
| Mar 31, 2022 | -4.85 Mn |
| Dec 31, 2021 | -1.79 Mn |
| Sep 30, 2021 | -1.56 Mn |
| Jun 30, 2021 | -3.23 Mn |
API Access
Oncotelic Therapeutics Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();